Under the watchful eye of the Federal Trade Commission, UnitedHealth Group and LHC Group have extended their merger agreement to March 28, 2023, with the deal expected to close sometime during the first quarter, according to a filing with the Securitie…
High-intensity billing during “treat and release” emergency department stays rose significantly from 2006 to 2019, and was partially fueled by factors such as changes in case mix and service offering expansions, according to a new study in Health Affairs.
Another lawsuit, another loss for a major insurer. What happened, exactly? I’m Jeff Lagasse with Healthcare Finance News and we’ll put that question and others under the microscope in this week’s Top Stories, including the FBI’s ongoing healthcare cybe…
The American Medical Association is thanking the Medicare Payment Advisory Commission (MedPAC) for acknowledging during its meeting on Thursday what it called the growing gap between the costs of practicing medicine and what Medicare pays.
The American Hospital Association has released
Upwards of 18 million people could lose Medicaid coverage, and four million people could become uninsured entirely when the COVID-19 public health emergency expires next year, according to a recently published analysis from the Urban Institute.
This co…
Upwards of 18 million people could lose Medicaid coverage, and four million people could become uninsured entirely when the COVID-19 public health emergency expires next year, according to a recently published analysis from the Urban Institute.
This co…
BOSTON – The issue with cybersecurity from a clinical point of view is that physicians and nurses just want things to work. They often want cybersecurity to be bolted on to make patient information secure, according to experts speaking during the HIMSS…
Pfizer and Clear Creek Bio, a biotech startup based in Cambridge, Massachusetts, have partnered to develop a new COVID-19 treatment they hope will provide greater efficacy as the virus evolves and proves increasingly resistant to current treatments.
Pharmacy benefit manager Express Scripts, part of Cigna’s Evernorth subsidiary, will be adding Humira biosimilars to its formulary in 2023 as preferred products, which will be available to patients with inflammatory conditions.
